Infusion Pump Market - Global forecast to 2030
商品番号 : SMB-4478
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年6月 |
| ページ数 | 583 |
| 図表数 | 674 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本レポートは、輸液ポンプ市場を、種類、投与方法、用途、エンドユーザー、地域の観点から分析しています。また、市場の成長に影響を与える要因（促進要因、抑制要因、機会、課題）についても分析しています。市場の機会と課題を分析し、市場リーダー企業の競争環境の詳細を提供します。さらに、マイクロマーケットを個々の成長傾向に基づいて分析し、主要6地域および各国における市場セグメントの収益予測も示しています。
The infusion pump market is projected to grow from USD 19,863.5 million in 2025 to USD 28,345 million by 2030, at a CAGR of 7.4%. The increasing incidence of chronic diseases such as diabetes, cancer, and cardiovascular disorders necessitates the precise, controlled, and continuous delivery of pharmacological therapies, significantly propelling market growth for infusion pump technologies. Furthermore, advancements in device engineering have catalyzed the evolution of smart infusion systems equipped with wireless connectivity and dose-error reduction algorithms, thereby enhancing patient safety and improving the efficiency of drug administration. The shift towards home-based healthcare solutions, in contrast to traditional inpatient settings, is creating additional demand for these advanced delivery systems. Moreover, stringent regulatory frameworks and enhanced cybersecurity protocols surrounding infusion pumps are fostering the development of safer, more reliable systems, further reinforcing market expansion.
輸液ポンプ市場は、2025年の198億6,350万米ドルから2030年には283億4,500万米ドルに達し、年平均成長率（CAGR）7.4％で成長すると予測されています。糖尿病、がん、心血管疾患などの慢性疾患の発生率の増加により、薬物療法の正確で制御された継続的な投与が必要となり、輸液ポンプ技術の市場成長を大幅に促進しています。さらに、デバイスエンジニアリングの進歩により、ワイヤレス接続と投与量エラー削減アルゴリズムを備えたスマート輸液システムの進化が促進され、患者の安全性が高まり、薬剤投与の効率が向上しています。従来の入院環境とは対照的に、在宅ヘルスケアソリューションへの移行により、これらの高度な投与システムに対する需要が高まっています。さらに、輸液ポンプを取り巻く厳格な規制の枠組みと強化されたサイバーセキュリティプロトコルにより、より安全で信頼性の高いシステムの開発が促進され、市場拡大がさらに強化されています。
“By mode of administration, the intravenous mode of administration segment is projected to grow at the highest CAGR during the forecast period.”
The intravenous (IV) mode of administration segment is rapidly emerging as the leading growth area in the pharmaceutical market, primarily due to its critical role in the rapid and precise delivery of medications, particularly within acute and emergency care environments. IV administration provides enhanced bioavailability, a crucial factor for therapies necessitating immediate therapeutic effects, such as during surgical procedures or acute medical situations. The rising incidence of chronic conditions, notably cancer, which often necessitates the intravenous administration of chemotherapeutic agents, further propels the expansion of this market. Additionally, advancements in technology, such as smart infusion pumps equipped with dose-error reduction systems, have significantly improved the safety and efficiency of IV drug delivery. These innovations, combined with stringent regulatory frameworks and reinforced cybersecurity measures, have led to heightened patient compliance with IV therapies. The convergence of these technological advancements, optimized delivery systems, and standardized clinical practices solidifies IV administration’s position as the fastest-growing segment within the healthcare field.
“By application, the chemotherapy/oncology segment accounted for the largest market share in 2024.”
The oncology/chemotherapy segment represents the predominant market share within the infusion pump industry, largely attributed to the escalating incidence of cancer globally, which necessitates ongoing drug administration for effective treatment. According to the World Health Organization (WHO), cancer accounted for 20 million new cases in 2022, with projections estimating 35 million cases by 2050. Infusion pumps are critical for the delivery of chemotherapy agents, providing precise and controlled drug administration that enhances therapeutic efficacy while minimizing toxicity. The advent of portable and implantable infusion pumps has transitioned chemotherapy into home care environments, further driving the expansion of this segment. Moreover, advancements in infusion technology, such as smart infusion pumps featuring wireless connectivity and integration with electronic medical records (EMRs), have significantly propelled market growth and facilitated better patient management.
“The Asia Pacific region is expected to witness the highest growth rate during the forecast period.”
The Asia-Pacific region is emerging as the fastest-growing sector in the infusion pump market, largely due to significant demographic shifts, a rising incidence of chronic diseases, and advancements in healthcare infrastructure. Countries such as China, India, and Japan are witnessing an upsurge in chronic conditions—diabetes, cancer, and cardiovascular diseases—necessitating the implementation of continuous medication delivery systems like infusion pumps. This demand is exacerbated by the increasing geriatric population, which typically requires complex and long-term medical treatments. Moreover, regional governments are instrumental in bolstering market growth by amplifying investments in healthcare and enhancing infrastructure, thereby improving access to advanced medical technologies. Technological advancements, particularly the development of smart infusion pumps, are also playing a pivotal role in propelling market dynamics within the Asia-Pacific region. These innovations not only improve medication delivery precision but also allow for better patient monitoring and management, aligning with the evolving needs of healthcare systems in the region.
Breakdown of supply-side primary interviews:
- • By Company Type: Tier 1 (45%), Tier 2 (20%), and Tier 3 (35%)
- • By Designation: C-level Executives (35%), Directors (25%), and Other Designations (40%)
- • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)
Breakdown of demand-side primary interviews:
- • By Company Type: Hospitals (38%), Home Care Settings (25%), Ambulatory Care Settings (20%), Academic & Research Institutes (12%), Oncology Centers (3%), Other End Users (2%)
- • By Designation: Healthcare Professionals (35%), Department Heads (27%), Procurement Heads (22%), and Other Designations (16%)
- • By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and Middle East & Africa (5%)
Research Coverage
This report studies the infusion pump market based on type, mode of administration, application, end user, and region. It also studies factors affecting market growth (drivers, restraints, opportunities, and challenges). It analyzes the market’s opportunities and challenges and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to six main regions and respective countries.
Reasons to Buy the Report
The report can help established companies, and new or smaller firms understand market trends, which will help them capture a larger market share. Firms that purchase the report can utilize one or more of the five strategies mentioned below.
This report provides insights into the following points:
- Analysis of key drivers (rapid technological advancements in development of smart, connected, and automated pumps, heightened regulatory safety and cybersecurity requirements, increased shift to home care settings, rising prevalence of chronic diseases, and growing number of surgeries), restraints (increasing number of product recalls, stringent regulations for infusion pump approval, and rising adoption of refurbished and rental infusion pumps), opportunities (high growth potential in emerging economies, adoption of specialty infusion systems), and challenges (increase in medications errors and lack of wireless connectivity in hospitals) influencing the growth of infusion pump market.
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the infusion pump market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of infusion procedures across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the infusion pump market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the infusion pump market.
Table of Contents
1 INTRODUCTION 43
1.1 STUDY OBJECTIVES 43
1.2 MARKET DEFINITION 43
1.3 MARKET SCOPE 43
1.3.1 MARKETS SEGMENTATION 44
1.3.2 YEARS CONSIDERED 45
1.3.3 INCLUSIONS AND EXCLUSIONS 45
1.3.4 CURRENCY CONSIDERED 46
1.4 MARKET STAKEHOLDERS 46
1.5 LIMITATIONS 47
1.6 SUMMARY OF CHANGES 47
2 RESEARCH METHODOLOGY 49
2.1 RESEARCH APPROACH 49
2.2 RESEARCH METHODOLOGY DESIGN 49
2.2.1 SECONDARY RESEARCH 50
2.2.1.1 Key data from secondary sources 51
2.2.2 PRIMARY DATA 52
2.2.2.1 Key data from primary sources 53
2.2.2.2 Key industry insights 53
2.3 MARKET SIZE ESTIMATION 55
2.3.1 BOTTOM-UP APPROACH 61
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 63
2.5 MARKET SHARE ANALYSIS 64
2.6 MARKET ASSUMPTIONS 64
2.6.1 INFUSION PUMPS MARKET: ASSUMPTION ANALYSIS 64
2.6.2 GROWTH RATE ASSUMPTIONS 65
2.7 RISK ASSESSMENT 65
2.8 LIMITATIONS 65
2.8.1 METHODOLOGY-RELATED LIMITATIONS 65
2.8.2 SCOPE-RELATED LIMITATIONS 66
3 EXECUTIVE SUMMARY 67
4 PREMIUM INSIGHTS 78
4.1 INFUSION PUMPS MARKET OVERVIEW 78
4.2 ASIA PACIFIC: INFUSION PUMPS MARKET, BY APPLICATION & COUNTRY (2024) 79
4.3 INFUSION PUMPS MARKET: REGIONAL MIX 80
4.4 INFUSION PUMPS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 81
4.5 INFUSION PUMPS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS 82
5 MARKET OVERVIEW 83
5.1 INTRODUCTION 83
5.2 MARKET DYNAMICS 84
5.2.1 DRIVERS 84
5.2.1.1 Technological innovation for development of automated pumps 84
5.2.1.2 Stringent regulatory guidelines for safety & cybersecurity requirements 85
5.2.1.3 Increasing demand for ambulatory infusion pumps in home care settings 85
5.2.1.4 Expanding geriatric population and subsequent rise in chronic diseases 86
5.2.1.5 Rising number of surgical procedures 88
5.2.2 RESTRAINTS 89
5.2.2.1 Product recalls 89
5.2.2.2 Complex regulatory process for product commercialization 92
5.2.2.3 Increasing adoption of refurbished & rental infusion pumps 93
5.2.3 OPPORTUNITIES 94
5.2.3.1 Growth potential of emerging economies 94
5.2.3.2 Increasing adoption of specialty infusion systems 94
5.2.4 CHALLENGES 95
5.2.4.1 Rising incidence of medication errors and lack of wireless connectivity in hospitals 95
5.3 INDUSTRY TRENDS 96
5.3.1 GROWING FOCUS ON SMART PUMP-EMR INTEROPERABILITY 96
5.3.2 DEVELOPMENT OF HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS 98
5.3.3 INCREASING DEMAND FOR SPECIALTY PUMPS AND ADVANCED FEATURES 99
5.4 TECHNOLOGY ANALYSIS 100
5.4.1 KEY TECHNOLOGIES 100
5.4.1.1 Flow generation 100
5.4.1.2 Smart infusion systems 100
5.4.1.3 Closed-loop infusion control systems 101
5.4.2 COMPLEMENTARY TECHNOLOGIES 101
5.4.2.1 Dose-error reduction systems 101
5.4.2.2 Wireless connectivity 102
5.4.2.3 AI-powered decision support systems 102
5.4.3 ADJACENT TECHNOLOGIES 103
5.4.3.1 Embedded software 103
5.4.3.2 Sensing technology 103
5.4.3.3 Telemedicine platforms 104
5.5 PORTER’S FIVE FORCES ANALYSIS 105
5.5.1 THREAT OF NEW ENTRANTS 106
5.5.2 THREAT OF SUBSTITUTES 107
5.5.3 BARGAINING POWER OF SUPPLIERS 107
5.5.4 BARGAINING POWER OF BUYERS 108
5.5.5 INTENSITY OF COMPETITIVE RIVALRY 108
5.6 REGULATORY LANDSCAPE 108
5.6.1 REGULATORY ANALYSIS 108
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109
5.7 PATENT ANALYSIS 112
5.7.1 PATENT PUBLICATION TRENDS FOR INFUSION PUMPS 112
5.7.2 INSIGHTS: JURISDICTION & TOP APPLICANT ANALYSIS 113
5.8 TRADE ANALYSIS 115
5.8.1 TRADE DATA FOR HS CODE 901890 116
5.8.1.1 Import data for HS Code 901890 116
5.8.1.2 Export data for HS Code 901890 116
5.9 PRICING ANALYSIS 117
5.9.1 AVERAGE SELLING PRICE, BY KEY PLAYER 117
5.9.1.1 Average selling price trend of key players, by device 117
5.9.2 AVERAGE SELLING PRICE, BY REGION 119
5.9.2.1 Average selling price of volumetric infusion pumps, insulin pumps, and syringe infusion pumps, by region, 2024 120
5.9.2.2 Average selling price trend of volumetric infusion pumps,
by region, 2022−2024 120
5.9.2.3 Average selling price trend of insulin pumps, by region, 2022−2024 121
5.9.2.4 Average selling price trend of ambulatory infusion pumps,
by region, 2022−2024 121
5.9.2.5 Average selling price trend of syringe infusion pumps,
by region, 2022−2024 121
5.9.2.6 Average selling price trend of enteral infusion pumps, by region 122
5.9.2.7 Average selling price trend of PCA pumps, by region, 2022−2024 122
5.9.2.8 Average selling price trend of implantable infusion pumps, by region, 2022−2024 122
5.10 REIMBURSEMENT ANALYSIS 123
5.11 KEY CONFERENCES & EVENTS, 2025–2026 124
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 126
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 126
5.12.2 BUYING CRITERIA 126
5.13 UNMET NEEDS/END-USER EXPECTATIONS 127
5.14 IMPACT OF AI/GENERATIVE AI ON INFUSION PUMPS MARKET 128
5.14.1 INTRODUCTION 128
5.14.2 MARKET POTENTIAL OF INFUSION PUMPS ECOSYSTEM 128
5.14.3 AI USE CASES 129
5.14.4 KEY COMPANIES IMPLEMENTING AI IN INFUSION PUMPS 129
5.14.5 FUTURE OF GEN AI ACROSS INFUSION PUMPS ECOSYSTEM 130
5.15 ECOSYSTEM MARKET MAP 131
5.16 CASE STUDY ANALYSIS 132
5.16.1 RELIABILITY ANALYSIS OF HOSPITAL INFUSION PUMPS 132
5.16.2 NEXT GENERATION MEDICAL INFUSION PUMP 133
5.16.3 ENHANCEMENT OF MEDICATION DELIVERY WITH INTEROPERABILITY FEATURES OF SMART INFUSION PUMPS 134
5.17 SUPPLY/VALUE CHAIN ANALYSIS 134
5.18 ADJACENT MARKET ANALYSIS 136
5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 137
5.20 INVESTMENT & FUNDING SCENARIO 137
5.21 TRUMP TARIFF IMPACT ON INFUSION PUMPS MARKET 138
5.21.1 INTRODUCTION 138
5.21.2 KEY TARIFF RATES 139
5.21.3 PRICE IMPACT ANALYSIS 140
5.21.4 IMPACT ON COUNTRY/REGION 140
5.21.5 END-USE INDUSTRY IMPACT 142
6 INFUSION PUMPS MARKET, BY PRODUCT 144
6.1 INTRODUCTION 145
6.2 ACCESSORIES AND CONSUMABLES 147
6.2.1 DEDICATED ACCESSORIES AND CONSUMABLES 151
6.2.1.1 Volumetric infusion pump dedicated disposables 154
6.2.1.1.1 Growing installation for deliverance of medication & nutrients to boost demand 154
6.2.1.2 Insulin pump dedicated disposables 156
6.2.1.2.1 Rising number of insulin-dependent diabetic patients to support market growth 156
6.2.1.3 Enteral infusion pump dedicated disposables 158
6.2.1.3.1 Ability to provide precision & consistency in results to fuel market 158
6.2.1.4 Syringe infusion pump dedicated disposables 160
6.2.1.4.1 High demand in emerging economies to drive market 160
6.2.1.5 Ambulatory infusion pump dedicated disposables 162
6.2.1.5.1 Growing preference for home care settings to boost demand 162
6.2.1.6 PCA pump dedicated disposables 164
6.2.1.6.1 Growing focus on critical pain management to boost market 164
6.2.1.7 Implantable infusion pump dedicated disposables 166
6.2.1.7.1 Compatibility features to aid adoption 166
6.2.2 NON-DEDICATED ACCESSORIES AND CONSUMABLES 168
6.2.2.1 Infusion catheters 171
6.2.2.1.1 Potential for recurrent use to drive demand 171
6.2.2.2 IV administration sets 173
6.2.2.2.1 Rising demand across various systems to propel market 173
6.2.2.3 Needleless connectors 175
6.2.2.3.1 Reduction in bloodstream infection risks to drive demand 175
6.2.2.4 Cannulas 177
6.2.2.4.1 Ability to ease patient discomfort to boost demand 177
6.2.2.5 Tubing and extension sets 179
6.2.2.5.1 Need for continuous and efficient connections to drive market 179
6.2.2.6 Valves 181
6.2.2.6.1 Improvement in infusion quality to drive market 181
6.2.2.7 Other non-dedicated accessories and consumables 183
6.3 DEVICES 185
6.3.1 DEVICES MARKET, BY TYPE 186
6.3.1.1 Volumetric infusion pumps 188
6.3.1.1.1 Technological improvements to boost market 188
6.3.1.2 Insulin pumps 191
6.3.1.2.1 High demand for diabetes to propel market 191
6.3.1.3 Ambulatory infusion pumps 194
6.3.1.3.1 Disposable infusion pumps 197
6.3.1.3.1.1 Portability & ease of operation to fuel demand 197
6.3.1.3.2 Chemotherapy infusion pumps 199
6.3.1.3.2.1 Growing focus on injecting oncology drugs in home care settings to fuel uptake 199
6.3.1.4 Syringe infusion pumps 201
6.3.1.4.1 Cost-effectiveness and portability to drive market 201
6.3.1.5 Enteral infusion pumps 204
6.3.1.5.1 Technological advancements to bolster market 204
6.3.1.6 PCA pumps 207
6.3.1.6.1 Pre-programmed delivery of fixed number of analgesics to fuel adoption 207
6.3.1.7 Implantable infusion pumps 209
6.3.1.7.1 Growing use for long-term delivery of opioid medication to drive market 209
6.3.2 DEVICES MARKET, BY TECHNOLOGY 212
6.3.2.1 Traditional infusion pumps 212
6.3.2.1.1 Utilization across long-term care settings to drive market 212
6.3.2.2 Specialty infusion pumps 215
6.3.2.2.1 Lightweight mobility to fuel uptake 215
6.3.3 DEVICES MARKET, BY MODE 217
6.3.3.1 Stationary infusion pumps 217
6.3.3.1.1 Ability to deliver medication through multiple routes to support market uptake 217
6.3.3.2 Portable infusion pumps 219
6.3.3.2.1 Convenience and remote availability to boost demand 219
7 INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION 221
7.1 INTRODUCTION 222
7.2 INTRAVENOUS (IV) 222
7.2.1 RAPID AND CONTROLLED DIRECT DELIVERY TO PROPEL MARKET 222
7.3 SUBCUTANEOUS 225
7.3.1 ADMINISTRATION OF MEDICATIONS INTO TISSUE LAYERS FOR SLOW & SUSTAINED RELEASE TO FUEL UPTAKE 225
7.4 EPIDURAL 227
7.4.1 ANALGESIC/ANESTHETIC AGENT TRANSMISSION FOR TARGETED PAIN RELIEF TO DRIVE MARKET 227
7.5 ENTERAL 229
7.5.1 ADOPTION OF PORTABLE & SMART ENTERAL INFUSION SYSTEMS TO SUPPORT MARKET GROWTH 229
7.6 INTRATHECAL 231
7.6.1 MEDICATION DELIVERY FOR CHRONIC PAIN RELIEF & MANAGEMENT TO FUEL UPTAKE 231
8 INFUSION PUMPS MARKET, BY END USER 233
8.1 INTRODUCTION 234
8.2 HOSPITALS 235
8.2.1 HIGH PURCHASING POWER FOR TECHNOLOGICALLY ADVANCED INFUSION DEVICES TO DRIVE MARKET 235
8.3 HOME CARE SETTINGS 237
8.3.1 DEVELOPMENT OF COMPACT & PORTABLE DEVICES TO BOOST DEMAND 237
8.4 AMBULATORY CARE SETTINGS 239
8.4.1 GROWING AVAILABILITY ACROSS CRITICAL CARE SETTINGS TO DRIVE MARKET 239
8.5 ACADEMIC & RESEARCH INSTITUTES 241
8.5.1 INCREASING FOCUS ON R&D ACTIVITIES FOR THERAPEUTIC CLINCIAL TRIALS TO AID MARKET 241
8.6 ONCOLOGY CENTERS 243
8.6.1 INCREASING REQUIREMENT FOR PRECISE & CONTROLLED DELIVERY OF CHEOMOTHERAPIC AGENTS TO SUPPORT MARKET GROWTH 243
8.7 OTHER END USERS 245
9 INFUSION PUMPS MARKET, BY APPLICATION 246
9.1 INTRODUCTION 247
9.2 CHEMOTHERAPY/ONCOLOGY 247
9.2.1 HIGH INCIDENCE OF CANCER AND GROWING DEVELOPMENT OF ONCOLOGY THERAPEUTICS TO DRIVE MARKET 247
9.3 DIABETES MANAGEMENT 250
9.3.1 INCREASING FOCUS ON SUSTAINED MEDICATION DELIVERY TO BOOST DEMAND 250
9.4 GASTROENTEROLOGY 253
9.4.1 INCREASING PREVALENCE OF IBD AND GASTROINTESTINAL INFECTIONS TO FUEL UPTAKE 253
9.5 ANALGESIA/PAIN MANAGEMENT 256
9.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO PROPEL MARKET 256
9.6 PEDIATRICS/NEONATOLOGY 258
9.6.1 INCREASING INCIDENCE OF PEDIATRIC DIABETES TO SUPPORT MARKET GROWTH 258
9.7 HEMATOLOGY 260
9.7.1 INCREASING PREVALENCE OF ANEMIA AND BLOOD DISORDERS TO FUEL UPTAKE 260
9.8 OTHER APPLICATIONS 262
10 INFUSION PUMPS MARKET, BY REGION 264
10.1 INTRODUCTION 265
10.2 NORTH AMERICA 266
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 266
10.2.2 US 273
10.2.2.1 Expansion in home care settings to fuel market 273
10.2.3 CANADA 278
10.2.3.1 Increasing incidence of chronic diseases to drive market 278
10.3 EUROPE 284
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 285
10.3.2 GERMANY 291
10.3.2.1 Presence of leading infusion pump manufacturers to drive market 291
10.3.3 FRANCE 297
10.3.3.1 Well-established healthcare system to support market growth 297
10.3.4 UK 303
10.3.4.1 NHS Digital Strategy and Homecare Shift Accelerate Infusion Pump Adoption in the UK 303
10.3.5 SPAIN 309
10.3.5.1 Rising prevalence of cancer to drive demand 309
10.3.6 ITALY 315
10.3.6.1 Growing demand for cost-effective home care to drive market 315
10.3.7 NETHERLANDS 321
10.3.7.1 Strong healthcare infrastructure and aging population to drive market 321
10.3.8 REST OF EUROPE 327
10.4 ASIA PACIFIC 333
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 334
10.4.2 CHINA 341
10.4.2.1 Growing investments in healthcare infrastructure to drive market 341
10.4.3 JAPAN 347
10.4.3.1 Large geriatric population to drive demand 347
10.4.4 INDIA 353
10.4.4.1 Increasing demand for advanced medical treatment to boost market 353
10.4.5 THAILAND 359
10.4.5.1 Medical tourism to drive demand 359
10.4.6 VIETNAM 365
10.4.6.1 Rising prevalence of chronic conditions to boost demand 365
10.4.7 AUSTRALIA 371
10.4.7.1 Increasing incidence of cancer & diabetes to fuel uptake 371
10.4.8 SOUTH KOREA 376
10.4.8.1 Integration of smart technologies to boost demand 376
10.4.9 REST OF ASIA PACIFIC 382
10.5 LATIN AMERICA 387
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 387
10.5.2 BRAZIL 393
10.5.2.1 Rising healthcare expenditure to drive market 393
10.5.3 MEXICO 399
10.5.3.1 Growth in medical devices industry to fuel market 399
10.5.4 REST OF LATIN AMERICA 405
10.6 MIDDLE EAST & AFRICA 411
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 412
10.6.2 GCC COUNTRIES 417
10.6.2.1 Kingdom of Saudi Arabia (KSA) 423
10.6.2.1.1 Significant healthcare investments to fuel uptake 423
10.6.2.2 United Arab Emirates (UAE) 429
10.6.2.2.1 Integration of EMR into smart pumps to fuel adoption 429
10.6.2.3 Other GCC Countries 435
10.6.3 REST OF MIDDLE EAST & AFRICA 441
11 COMPETITIVE LANDSCAPE 448
11.1 OVERVIEW 448
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 448
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN INFUSION PUMPS MARKET 449
11.3 REVENUE ANALYSIS, 2020−2024 451
11.4 MARKET SHARE ANALYSIS, 2024 452
11.4.1 VOLUMETRIC INFUSION PUMPS MARKET 453
11.4.2 SYRINGE INFUSION PUMPS MARKET 453
11.4.3 INSULIN PUMPS MARKET 454
11.4.4 ENTERAL INFUSION PUMPS MARKET 454
11.4.5 US: INFUSION PUMPS MARKET SHARE ANALYSIS 455
11.4.6 EUROPE: INFUSION PUMPS MARKET SHARE ANALYSIS 456
11.4.7 US: INSULIN PUMPS MARKET SHARE ANALYSIS 456
11.4.8 RANKING OF KEY MARKET PLAYERS 457
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 458
11.5.1 STARS 459
11.5.2 EMERGING LEADERS 459
11.5.3 PERVASIVE PLAYERS 459
11.5.4 PARTICIPANTS 459
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 461
11.5.5.1 Company footprint 461
11.5.5.2 Region footprint 462
11.5.5.3 Product footprint 463
11.5.5.4 Mode of administration footprint 464
11.5.5.5 Application footprint 465
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 466
11.6.1 PROGRESSIVE COMPANIES 466
11.6.2 DYNAMIC COMPANIES 466
11.6.3 STARTING BLOCKS 466
11.6.4 RESPONSIVE COMPANIES 466
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 468
11.6.5.1 Detailed list of key startups/SME players 468
11.6.5.2 Competitive benchmarking of key emerging players/startups 469
11.7 BRAND/PRODUCT COMPARATIVE ANALYSIS 470
11.8 R&D EXPENDITURE OF KEY PLAYERS 471
11.9 COMPANY VALUATION & FINANCIAL METRICS 471
11.9.1 FINANCIAL METRICS 471
11.9.2 COMPANY VALUATION 472
11.10 COMPETITIVE SCENARIO 472
11.10.1 PRODUCT LAUNCHES & APPROVALS 472
11.10.2 DEALS 474
11.10.3 EXPANSIONS 475
11.10.4 OTHER DEVELOPMENTS 476
12 COMPANY PROFILES 477
12.1 KEY PLAYERS 477
12.1.1 BECTON, DICKINSON AND COMPANY 477
12.1.1.1 Business overview 477
12.1.1.2 Products offered 478
12.1.1.3 Recent developments 483
12.1.1.3.1 Product approvals 483
12.1.1.3.2 Deals 484
12.1.1.3.3 Expansions 484
12.1.1.3.4 Other developments 485
12.1.1.4 MnM view 485
12.1.1.4.1 Key strengths 485
12.1.1.4.2 Strategic choices 485
12.1.1.4.3 Weaknesses & competitive threats 486
12.1.2 BAXTER INTERNATIONAL, INC. 487
12.1.2.1 Business overview 487
12.1.2.2 Products offered 488
12.1.2.3 Recent developments 490
12.1.2.3.1 Product launches 490
12.1.2.3.2 Deals 490
12.1.2.3.3 Other developments 491
12.1.2.4 MnM view 491
12.1.2.4.1 Key strengths 491
12.1.2.4.2 Strategic choices 491
12.1.2.4.3 Weaknesses & competitive threats 492
12.1.3 B. BRAUN SE 493
12.1.3.1 Business overview 493
12.1.3.2 Products offered 494
12.1.3.3 Recent developments 497
12.1.3.3.1 Product launches & approvals 497
12.1.3.3.2 Deals 498
12.1.3.3.3 Other developments 498
12.1.3.4 MnM view 498
12.1.3.4.1 Key strengths 498
12.1.3.4.2 Strategic choices 499
12.1.3.4.3 Weaknesses & competitive threats 499
12.1.4 MEDTRONIC 500
12.1.4.1 Business overview 500
12.1.4.2 Products offered 501
12.1.4.3 Recent developments 502
12.1.4.3.1 Product launches & approvals 502
12.1.4.3.2 Deals 503
12.1.4.4 MnM view 504
12.1.4.4.1 Key strengths 504
12.1.4.4.2 Strategic choices 504
12.1.4.4.3 Weaknesses & competitive threats 505
12.1.5 FRESENIUS KABI AG 506
12.1.5.1 Business overview 506
12.1.5.2 Products offered 508
12.1.5.3 Recent developments 511
12.1.5.3.1 Product approvals 511
12.1.5.3.2 Deals 511
12.1.5.3.3 Other developments 512
12.1.5.4 MnM view 512
12.1.5.4.1 Key strengths 512
12.1.5.4.2 Strategic choices 513
12.1.5.4.3 Weaknesses & competitive threats 513
12.1.6 ICU MEDICAL, INC. 514
12.1.6.1 Business overview 514
12.1.6.2 Products offered 515
12.1.6.3 Recent developments 517
12.1.6.3.1 Product launches & approvals 517
12.1.6.3.2 Deals 517
12.1.6.3.3 Other developments 517
12.1.7 TERUMO CORPORATION 518
12.1.7.1 Business overview 518
12.1.7.2 Products offered 519
12.1.7.3 Recent developments 520
12.1.7.3.1 Product launches 520
12.1.7.3.2 Expansions 521
12.1.7.3.3 Deals 521
12.1.8 NIPRO 522
12.1.8.1 Business overview 522
12.1.8.2 Products offered 523
12.1.8.3 Recent developments 525
12.1.8.3.1 Expansions 525
12.1.9 AVANOS MEDICAL, INC. 526
12.1.9.1 Business overview 526
12.1.9.2 Products offered 528
12.1.10 INSULET CORPORATION 529
12.1.10.1 Business overview 529
12.1.10.2 Products offered 530
12.1.10.3 Recent developments 531
12.1.10.3.1 Product launches & approvals 531
12.1.10.3.2 Deals 532
12.1.10.3.3 Expansions 532
12.1.11 TANDEM DIABETES CARE, INC. 533
12.1.11.1 Business overview 533
12.1.11.2 Products offered 534
12.1.11.3 Recent developments 535
12.1.11.3.1 Product launches & approvals 535
12.1.11.3.2 Deals 536
12.1.12 JMS CO., LTD. 537
12.1.12.1 Business overview 537
12.1.12.2 Products offered 539
12.1.13 F. HOFFMANN-LA ROCHE LTD. 540
12.1.13.1 Business overview 540
12.1.13.2 Products offered 542
12.1.13.3 Recent developments 542
12.1.13.3.1 Other developments 542
12.1.14 MOOG, INC. 543
12.1.14.1 Business overview 543
12.1.14.2 Products offered 544
12.1.14.2.1 Product launches & enhancements 546
12.1.14.2.2 Other developments 546
12.1.15 TELEFLEX INCORPORATED 547
12.1.15.1 Business overview 547
12.1.15.2 Products offered 548
12.1.16 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 549
12.1.16.1 Business overview 549
12.1.16.2 Products offered 551
12.1.16.3 Recent developments 551
12.1.16.3.1 Product launches 551
12.1.17 YPSOMED 552
12.1.17.1 Business overview 552
12.1.17.2 Products offered 553
12.1.17.3 Recent developments 554
12.1.17.3.1 Product launches & enhancements 554
12.1.17.3.2 Deals 555
12.1.17.3.3 Expansions 556
12.1.18 POLYMEDICURE 557
12.1.18.1 Business overview 557
12.1.18.2 Products offered 558
12.1.19 ROMSONS.IN 560
12.1.19.1 Business overview 560
12.1.19.2 Products offered 561
12.1.20 PROMED TECHNOLOGY CO., LIMITED 562
12.1.20.1 Business overview 562
12.1.20.2 Products offered 562
12.1.21 MEDCAPTAIN MEDICAL TECHNOLOGY CO., LTD. 564
12.1.21.1 Business overview 564
12.1.21.2 Products offered 564
12.2 OTHER PLAYERS 566
12.2.1 MICREL MEDICAL DEVICES SA 566
12.2.2 INTUVIE HOLDINGS LLC 567
12.2.3 EPIC MEDICAL 568
12.2.4 SOOIL DEVELOPMENTS CO., LTD. 569
12.2.5 SHENZHEN MEDRENA BIOTECH CO., LTD 570
12.2.6 CODAN COMPANIES 571
12.2.7 EITAN MEDICAL 572
12.2.8 ANGIPLAST PRIVATE LIMITED 573
12.2.9 BEIJING KELLYMED CO. 574
13 APPENDIX 575
13.1 DISCUSSION GUIDE 575
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 579
13.3 RELATED REPORTS 581
13.4 AUTHOR DETAILS 582
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD UNIT) 46
TABLE 2 INFUSION PUMPS MARKET: RISK ASSESSMENT ANALYSIS 65
TABLE 3 DRIVERS: IMPACT ANALYSIS 88
TABLE 4 PRODUCT RECALLS DUE TO DEVICE-RELATED MEDICATION ERRORS
(JANUARY 2022–MAY 2025) 89
TABLE 5 INDICATIVE LIST OF PRODUCT RECALLS FOR INFUSION PUMPS
(JANUARY 2022–MAY 2025) 90
TABLE 6 RESTRAINTS: IMPACT ANALYSIS 93
TABLE 7 OPPORTUNITIES: IMPACT ANALYSIS 95
TABLE 8 CHALLENGES: IMPACT ANALYSIS 95
TABLE 9 RECENT DEVELOPMENTS IN SMART PUMP-EMR INTEROPERABILITY 96
TABLE 10 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO 98
TABLE 11 PORTER’S FIVE FORCES ANALYSIS 106
TABLE 12 STRINGENCY OF REGULATIONS FOR INFUSION PUMPS, BY REGION 109
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 109
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 110
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 110
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 111
TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 111
TABLE 18 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 112
TABLE 19 INFUSION PUMPS MARKET: KEY PATENTS 114
TABLE 20 IMPORT DATA FOR HS CODE 901890, BY COUNTRY,
2021–2024 (USD THOUSAND) 116
TABLE 21 EXPORT DATA FOR HS CODE 901890, BY COUNTRY,
2021–2024 (USD THOUSAND) 116
TABLE 22 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY DEVICE, 2022–2024 117
TABLE 23 AVERAGE SELLING PRICE TREND FOR NON-DEDICATED ACCESSORIES & CONSUMABLES, BY KEY PLAYER, 2022–2024 118
TABLE 24 AVERAGE SELLING PRICE TREND OF VOLUMETRIC INFUSION PUMPS,
BY REGION, 2022–2024 120
TABLE 25 AVERAGE SELLING PRICE TREND FOR INSULIN PUMPS, BY REGION, 2022–2024 121
TABLE 26 AVERAGE SELLING PRICE TREND OF AMBULATORY INFUSION PUMPS,
BY REGION, 2022–2024 121
TABLE 27 AVERAGE SELLING PRICE TREND OF SYRINGE INFUSION PUMPS,
BY REGION, 2022–2024 121
TABLE 28 AVERAGE SELLING PRICE TREND OF ENTERAL INFUSION PUMPS,
BY REGION, 2022–2024 122
TABLE 29 AVERAGE SELLING PRICE TREND OF PCA PUMPS, BY REGION, 2022–2024 122
TABLE 30 AVERAGE SELLING PRICE TREND OF IMPLANTABLE INFUSION PUMPS,
BY REGION, 2022–2024 122
TABLE 31 INFUSION PUMPS MARKET: KEY CONFERENCES & EVENTS, 2025–2026 124
TABLE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INFUSION PUMPS (%) 126
TABLE 33 KEY COMPANIES IMPLEMENTING AI IN INFUSION PUMPS 130
TABLE 34 INFUSION PUMP PROVIDERS: ROLE OF COMPANIES 132
TABLE 35 CASE STUDY 1: RELIABILITY ANALYSIS OF HOSPITAL INFUSION PUMPS 132
TABLE 36 CASE STUDY 2: NEXT-GENERATION MEDICAL INFUSION PUMP 133
TABLE 37 CASE STUDY 3: ENHANCEMENT OF MEDICATION DELIVERY WITH INTEROPERABILITY FEATURES OF SMART INFUSION PUMPS 134
TABLE 38 US ADJUSTED RECIPROCAL TARIFF RATES 139
TABLE 39 KEY PRODUCT-RELATED TARIFF EFFECTIVE INFUSION PUMPS 140
TABLE 40 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 140
TABLE 41 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 141
TABLE 42 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 142
TABLE 43 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 142
TABLE 44 INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 145
TABLE 45 INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 46 KEY PLAYERS PROVIDING INFUSION PUMP ACCESSORIES AND CONSUMABLES 147
TABLE 47 INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 48 INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY COUNTRY, 2023–2030 (USD MILLION) 150
TABLE 49 KEY PLAYERS PROVIDING DEDICATED ACCESSORIES AND CONSUMABLES 151
TABLE 50 DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 152
TABLE 51 DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 153
TABLE 52 KEY PLAYERS PROVIDING VOLUMETRIC INFUSION PUMP DEDICATED DISPOSABLES 154
TABLE 53 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR VOLUMETRIC INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION) 155
TABLE 54 KEY PLAYERS PROVIDING INSULIN PUMP DEDICATED DISPOSABLES 156
TABLE 55 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR INSULIN PUMPS,
BY COUNTRY, 2023–2030 (USD MILLION) 157
TABLE 56 KEY PLAYERS PROVIDING ENTERAL INFUSION PUMP DEDICATED DISPOSABLES 158
TABLE 57 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR ENTERAL INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 58 KEY PLAYERS PROVIDING SYRINGE INFUSION PUMP DEDICATED DISPOSABLES 160
TABLE 59 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR SYRINGE INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION) 161
TABLE 60 KEY PLAYERS PROVIDING AMBULATORY INFUSION PUMP DEDICATED DISPOSABLES 162
TABLE 61 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR AMBULATORY INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 62 KEY PLAYERS PROVIDING PCA PUMP DEDICATED DISPOSABLES 164
TABLE 63 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR PCA PUMPS,
BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 64 KEY PLAYERS PROVIDING IMPLANTABLE INFUSION PUMP DEDICATED DISPOSABLES 166
TABLE 65 DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR IMPLANTABLE INFUSION PUMPS, BY COUNTRY, 2023–2030 (USD MILLION) 167
TABLE 66 KEY PLAYERS PROVIDING NON-DEDICATED ACCESSORIES AND CONSUMABLES 168
TABLE 67 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 169
TABLE 68 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170
TABLE 69 KEY PLAYERS PROVIDING INFUSION CATHETERS 171
TABLE 70 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR INFUSION CATHETERS, BY COUNTRY, 2023–2030 (USD MILLION) 172
TABLE 71 KEY PLAYERS PROVIDING IV ADMINISTRATION SETS 173
TABLE 72 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR IV ADMINISTRATION SETS, BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 73 KEY PLAYERS PROVIDING NEEDLELESS CONNECTORS 175
TABLE 74 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR NEEDLELESS CONNECTORS, BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 75 KEY PLAYERS PROVIDING CANNULAS 177
TABLE 76 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR CANNULAS,
BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 77 KEY PLAYERS PROVIDING TUBING AND EXTENSION SETS 179
TABLE 78 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR TUBING AND EXTENSION SETS, BY COUNTRY, 2023–2030 (USD MILLION) 180
TABLE 79 KEY PLAYERS PROVIDING VALVES 181
TABLE 80 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET FOR VALVES,
BY COUNTRY, 2023–2030 (USD MILLION) 182
TABLE 81 KEY PLAYERS PROVIDING OTHER NON-DEDICATED ACCESSORIES AND CONSUMABLES 183
TABLE 82 OTHER NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 184
TABLE 83 KEY PLAYERS PROVIDING INFUSION PUMP DEVICES 185
TABLE 84 INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 186
TABLE 85 INFUSION PUMP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187
TABLE 86 KEY PLAYERS PROVIDING VOLUMETRIC INFUSION PUMPS 189
TABLE 87 VOLUMETRIC INFUSION PUMPS MARKET, BY REGION,
2023–2030 (THOUSAND UNITS) 189
TABLE 88 VOLUMETRIC INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 190
TABLE 89 KEY PLAYERS PROVIDING INSULIN PUMPS 192
TABLE 90 INSULIN PUMPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 192
TABLE 91 INSULIN PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 193
TABLE 92 KEY PLAYERS PROVIDING AMBULATORY INFUSION PUMPS 194
TABLE 93 AMBULATORY INFUSION PUMPS MARKET, BY REGION,
2023–2030 (THOUSAND UNITS) 195
TABLE 94 AMBULATORY INFUSION PUMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 195
TABLE 95 AMBULATORY INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 196
TABLE 96 KEY PLAYERS PROVIDING DISPOSABLE INFUSION PUMPS 197
TABLE 97 DISPOSABLE INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 198
TABLE 98 KEY PLAYERS PROVIDING CHEMOTHERAPY INFUSION PUMPS 199
TABLE 99 CHEMOTHERAPY INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 200
TABLE 100 KEY PLAYERS PROVIDING SYRINGE INFUSION PUMPS 201
TABLE 101 SYRINGE INFUSION PUMPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 202
TABLE 102 SYRINGE INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 203
TABLE 103 KEY PLAYERS PROVIDING ENTERAL INFUSION PUMPS 204
TABLE 104 ENTERAL INFUSION PUMPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 205
TABLE 105 ENTERAL INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 206
TABLE 106 KEY PLAYERS PROVIDING PCA PUMPS 207
TABLE 107 PCA PUMPS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 207
TABLE 108 PCA PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 208
TABLE 109 KEY PLAYERS PROVIDING IMPLANTABLE INFUSION PUMPS 210
TABLE 110 IMPLANTABLE INFUSION PUMPS MARKET, BY REGION,
2023–2030 (THOUSAND UNITS) 210
TABLE 111 IMPLANTABLE INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 211
TABLE 112 INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 212
TABLE 113 KEY PLAYERS PROVIDING TRADITIONAL INFUSION PUMPS 213
TABLE 114 TRADITIONAL INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 214
TABLE 115 KEY PLAYERS PROVIDING SPECIALTY INFUSION PUMPS 215
TABLE 116 SPECIALTY INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 216
TABLE 117 INFUSION PUMP DEVICES MARKET, BY MODE, 2023–2030 (USD MILLION) 217
TABLE 118 KEY PLAYERS PROVIDING STATIONARY INFUSION PUMPS 217
TABLE 119 STATIONARY INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 218
TABLE 120 KEY PLAYERS PROVIDING PORTABLE INFUSION PUMPS 219
TABLE 121 PORTABLE INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 220
TABLE 122 INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 222
TABLE 123 KEY PLAYERS PROVIDING INTRAVENOUS MODE OF ADMINISTRATION 223
TABLE 124 INFUSION PUMPS MARKET FOR INTRAVENOUS ADMINISTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 224
TABLE 125 KEY PLAYERS PROVIDING SUBCUTANEOUS MODE OF ADMINISTRATION 225
TABLE 126 INFUSION PUMPS MARKET FOR SUBCUTANEOUS ADMINISTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 226
TABLE 127 KEY PLAYERS PROVIDING EPIDURAL MODE OF ADMINISTRATION 227
TABLE 128 INFUSION PUMPS MARKET FOR EPIDURAL ADMINISTRATION, BY COUNTRY,
2023–2030 (USD MILLION) 228
TABLE 129 KEY PLAYERS PROVIDING ENTERAL MODE OF ADMINISTRATION 229
TABLE 130 INFUSION PUMPS MARKET FOR ENTERAL ADMINISTRATION, BY COUNTRY,
2023–2030 (USD MILLION) 230
TABLE 131 KEY PLAYERS PROVIDING INTRATHECAL MODE OF ADMINISTRATION 231
TABLE 132 INFUSION PUMPS MARKET FOR INTRATHECAL ADMINISTRATION, BY COUNTRY, 2023–2030 (USD MILLION) 232
TABLE 133 INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 234
TABLE 134 INFUSION PUMPS MARKET FOR HOSPITALS, BY COUNTRY,
2023–2030 (USD MILLION) 236
TABLE 135 INFUSION PUMPS MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2023–2030 (USD MILLION) 238
TABLE 136 INFUSION PUMPS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 240
TABLE 137 INFUSION PUMPS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY COUNTRY, 2023–2030 (USD MILLION) 242
TABLE 138 INFUSION PUMPS MARKET FOR ONCOLOGY CENTERS, BY COUNTRY,
2023–2030 (USD MILLION) 244
TABLE 139 INFUSION PUMPS MARKET FOR OTHER END USERS, BY COUNTRY,
2023–2030 (USD MILLION) 245
TABLE 140 INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 247
TABLE 141 KEY PLAYERS PROVIDING INFUSION PUMPS FOR CHEMOTHERAPY/
ONCOLOGY APPLICATIONS 248
TABLE 142 INFUSION PUMPS MARKET FOR CHEMOTHERAPY/ONCOLOGY, BY COUNTRY, 2023–2030 (USD MILLION) 249
TABLE 143 KEY PLAYERS PROVIDING INFUSION PUMPS FOR DIABETES MANAGEMENT 251
TABLE 144 INFUSION PUMPS MARKET FOR DIABETES MANAGEMENT, BY COUNTRY,
2023–2030 (USD MILLION) 252
TABLE 145 DISORDERS ASSOCIATED WITH DIGESTIVE SYSTEM 253
TABLE 146 KEY PLAYERS PROVIDING INFUSION PUMPS FOR GASTROENTEROLOGY APPLICATIONS 254
TABLE 147 INFUSION PUMP S MARKET FOR GASTROENTEROLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 255
TABLE 148 KEY PLAYERS PROVIDING INFUSION PUMPS FOR ANALGESIA/PAIN MANAGEMENT APPLICATIONS 256
TABLE 149 INFUSION PUMPS MARKET FOR ANALGESIA/PAIN MANAGEMENT, BY COUNTRY, 2023–2030 (USD MILLION) 257
TABLE 150 KEY PLAYERS PROVIDING INFUSION PUMPS FOR PEDIATRICS/ NEONATOLOGY APPLICATIONS 258
TABLE 151 INFUSION PUMPS MARKET FOR PEDIATRIC/NEONATOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 259
TABLE 152 KEY PLAYERS PROVIDING INFUSION PUMPS FOR HEMATOLOGY APPLICATIONS 260
TABLE 153 INFUSION PUMPS MARKET FOR HEMATOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 261
TABLE 154 KEY PLAYERS PROVIDING INFUSION PUMPS FOR OTHER APPLICATIONS 262
TABLE 155 INFUSION PUMPS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2023–2030 (USD MILLION) 263
TABLE 156 INFUSION PUMPS MARKET, BY REGION, 2023–2030 (USD MILLION) 266
TABLE 157 NORTH AMERICA: INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 268
TABLE 158 NORTH AMERICA: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 268
TABLE 159 NORTH AMERICA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 268
TABLE 160 NORTH AMERICA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 161 NORTH AMERICA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 162 NORTH AMERICA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 270
TABLE 163 NORTH AMERICA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 270
TABLE 164 NORTH AMERICA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 271
TABLE 165 NORTH AMERICA: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 271
TABLE 166 NORTH AMERICA: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 271
TABLE 167 NORTH AMERICA: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 272
TABLE 168 NORTH AMERICA: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 272
TABLE 169 US: KEY MACROINDICATORS 273
TABLE 170 US: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 274
TABLE 171 US: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 274
TABLE 172 US: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 275
TABLE 173 US: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 174 US: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 276
TABLE 175 US: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 276
TABLE 176 US: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 276
TABLE 177 US: INFUSION PUMP DEVICES MARKET, BY MODE, 2023–2030 (USD MILLION) 277
TABLE 178 US: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 277
TABLE 179 US: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 278
TABLE 180 US: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 278
TABLE 181 CANADA: KEY MACROINDICATORS 279
TABLE 182 CANADA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 279
TABLE 183 CANADA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 184 CANADA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 280
TABLE 185 CANADA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 186 CANADA: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 187 CANADA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 282
TABLE 188 CANADA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 282
TABLE 189 CANADA: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 282
TABLE 190 CANADA: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 283
TABLE 191 CANADA: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 283
TABLE 192 CANADA: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 284
TABLE 193 EUROPE: INFUSION PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 286
TABLE 194 EUROPE: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 286
TABLE 195 EUROPE: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 287
TABLE 196 EUROPE: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 287
TABLE 197 EUROPE: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288
TABLE 198 EUROPE: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288
TABLE 199 EUROPE: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 289
TABLE 200 EUROPE: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 289
TABLE 201 EUROPE: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 289
TABLE 202 EUROPE: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 290
TABLE 203 EUROPE: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 290
TABLE 204 EUROPE: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 291
TABLE 205 GERMANY: KEY MACROINDICATORS 292
TABLE 206 GERMANY: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 292
TABLE 207 GERMANY: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 208 GERMANY: DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 209 GERMANY: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 294
TABLE 210 GERMANY: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 294
TABLE 211 GERMANY: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 295
TABLE 212 GERMANY: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 295
TABLE 213 GERMANY: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 295
TABLE 214 GERMANY: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 296
TABLE 215 GERMANY: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 296
TABLE 216 GERMANY: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 297
TABLE 217 FRANCE: KEY MACROINDICATORS 298
TABLE 218 FRANCE: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 298
TABLE 219 FRANCE: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 220 FRANCE: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 221 FRANCE: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 222 FRANCE: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 223 FRANCE: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 301
TABLE 224 FRANCE: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 301
TABLE 225 FRANCE: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 301
TABLE 226 FRANCE: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 302
TABLE 227 FRANCE: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 302
TABLE 228 FRANCE: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 303
TABLE 229 UK: KEY MACROINDICATORS 304
TABLE 230 UK: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 304
TABLE 231 UK: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 305
TABLE 232 UK: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 305
TABLE 233 UK: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 234 UK: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 306
TABLE 235 UK: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 307
TABLE 236 UK: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 307
TABLE 237 UK: INFUSION PUMP DEVICES MARKET, BY MODE, 2023–2030 (USD MILLION) 307
TABLE 238 UK: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 308
TABLE 239 UK: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 308
TABLE 240 UK: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 309
TABLE 241 SPAIN: KEY MACROINDICATORS 310
TABLE 242 SPAIN: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 310
TABLE 243 SPAIN: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 310
TABLE 244 SPAIN: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 311
TABLE 245 SPAIN: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 311
TABLE 246 SPAIN: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 312
TABLE 247 SPAIN: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 312
TABLE 248 SPAIN: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 312
TABLE 249 SPAIN: INFUSION PUMP DEVICES MARKET, BY MODE, 2023–2030 (USD MILLION) 313
TABLE 250 SPAIN: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 313
TABLE 251 SPAIN: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 314
TABLE 252 SPAIN: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 314
TABLE 253 ITALY: KEY MACROINDICATORS 316
TABLE 254 ITALY: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 316
TABLE 255 ITALY: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 316
TABLE 256 ITALY: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 317
TABLE 257 ITALY: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 318
TABLE 258 ITALY: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 318
TABLE 259 ITALY: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 319
TABLE 260 ITALY: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 319
TABLE 261 ITALY: INFUSION PUMP DEVICES MARKET, BY MODE, 2023–2030 (USD MILLION) 319
TABLE 262 ITALY: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 320
TABLE 263 ITALY: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 320
TABLE 264 ITALY: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 321
TABLE 265 NETHERLANDS: KEY MACROINDICATORS 322
TABLE 266 NETHERLANDS: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 322
TABLE 267 NETHERLANDS: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 322
TABLE 268 NETHERLANDS: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 323
TABLE 269 NETHERLANDS: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 324
TABLE 270 NETHERLANDS: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 324
TABLE 271 NETHERLANDS: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 325
TABLE 272 NETHERLANDS: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 325
TABLE 273 NETHERLANDS: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 325
TABLE 274 NETHERLANDS: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 326
TABLE 275 NETHERLANDS: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 326
TABLE 276 NETHERLANDS: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 327
TABLE 277 REST OF EUROPE: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 328
TABLE 278 REST OF EUROPE: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 328
TABLE 279 REST OF EUROPE: DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 329
TABLE 280 REST OF EUROPE: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 330
TABLE 281 REST OF EUROPE: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 330
TABLE 282 REST OF EUROPE: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 331
TABLE 283 REST OF EUROPE: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 331
TABLE 284 REST OF EUROPE: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 331
TABLE 285 REST OF EUROPE: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 332
TABLE 286 REST OF EUROPE: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 332
TABLE 287 REST OF EUROPE: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 333
TABLE 288 ASIA PACIFIC: INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 336
TABLE 289 ASIA PACIFIC: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 336
TABLE 290 ASIA PACIFIC: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 337
TABLE 291 ASIA PACIFIC: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 337
TABLE 292 ASIA PACIFIC: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 338
TABLE 293 ASIA PACIFIC: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 338
TABLE 294 ASIA PACIFIC: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 339
TABLE 295 ASIA PACIFIC: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 339
TABLE 296 ASIA PACIFIC: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 339
TABLE 297 ASIA PACIFIC: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 340
TABLE 298 ASIA PACIFIC: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 340
TABLE 299 ASIA PACIFIC: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 341
TABLE 300 CHINA: MACROECONOMIC INDICATORS 342
TABLE 301 CHINA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 342
TABLE 302 CHINA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 343
TABLE 303 CHINA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 343
TABLE 304 CHINA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 344
TABLE 305 CHINA: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 344
TABLE 306 CHINA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 345
TABLE 307 CHINA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 345
TABLE 308 CHINA: INFUSION PUMP DEVICES MARKET, BY MODE, 2023–2030 (USD MILLION) 345
TABLE 309 CHINA: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 346
TABLE 310 CHINA: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 346
TABLE 311 CHINA: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 347
TABLE 312 JAPAN: MACROECONOMIC INDICATORS 348
TABLE 313 JAPAN: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 348
TABLE 314 JAPAN: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 348
TABLE 315 JAPAN: DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 349
TABLE 316 JAPAN: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 349
TABLE 317 JAPAN: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 350
TABLE 318 JAPAN: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 350
TABLE 319 JAPAN: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 350
TABLE 320 JAPAN: INFUSION PUMP DEVICES MARKET, BY MODE, 2023–2030 (USD MILLION) 351
TABLE 321 JAPAN: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 351
TABLE 322 JAPAN: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 352
TABLE 323 JAPAN: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 352
TABLE 324 INDIA: MACROECONOMIC INDICATORS 353
TABLE 325 INDIA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 354
TABLE 326 INDIA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 354
TABLE 327 INDIA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 355
TABLE 328 INDIA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 356
TABLE 329 INDIA: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 356
TABLE 330 INDIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 357
TABLE 331 INDIA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 357
TABLE 332 INDIA: INFUSION PUMP DEVICES MARKET, BY MODE, 2023–2030 (USD MILLION) 357
TABLE 333 INDIA: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 358
TABLE 334 INDIA: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 358
TABLE 335 INDIA: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 359
TABLE 336 THAILAND: MACROECONOMIC INDICATORS 360
TABLE 337 THAILAND: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 360
TABLE 338 THAILAND: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY PRODUCT, 2023–2030 (USD MILLION) 360
TABLE 339 THAILAND: DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 361
TABLE 340 THAILAND: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 362
TABLE 341 THAILAND: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 362
TABLE 342 THAILAND: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 363
TABLE 343 THAILAND: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 363
TABLE 344 THAILAND: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 363
TABLE 345 THAILAND: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 364
TABLE 346 THAILAND: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 364
TABLE 347 THAILAND: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 365
TABLE 348 VIETNAM: MACROECONOMIC INDICATORS 366
TABLE 349 VIETNAM: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 366
TABLE 350 VIETNAM: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 366
TABLE 351 VIETNAM: DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 367
TABLE 352 VIETNAM: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 367
TABLE 353 VIETNAM: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 368
TABLE 354 VIETNAM: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 368
TABLE 355 VIETNAM: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 369
TABLE 356 VIETNAM: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 369
TABLE 357 VIETNAM: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 369
TABLE 358 VIETNAM: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 370
TABLE 359 VIETNAM: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 370
TABLE 360 AUSTRALIA: KEY MACROINDICATORS 371
TABLE 361 AUSTRALIA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 371
TABLE 362 AUSTRALIA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 372
TABLE 363 AUSTRALIA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 372
TABLE 364 AUSTRALIA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 373
TABLE 365 AUSTRALIA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 373
TABLE 366 AUSTRALIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 374
TABLE 367 AUSTRALIA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 374
TABLE 368 AUSTRALIA: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 374
TABLE 369 AUSTRALIA: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 375
TABLE 370 AUSTRALIA: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 375
TABLE 371 AUSTRALIA: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 376
TABLE 372 SOUTH KOREA: MACROECONOMIC INDICATORS 377
TABLE 373 SOUTH KOREA: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 377
TABLE 374 SOUTH KOREA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 377
TABLE 375 SOUTH KOREA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 378
TABLE 376 SOUTH KOREA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 379
TABLE 377 SOUTH KOREA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 379
TABLE 378 SOUTH KOREA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 380
TABLE 379 SOUTH KOREA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 380
TABLE 380 SOUTH KOREA: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 380
TABLE 381 SOUTH KOREA: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 381
TABLE 382 SOUTH KOREA: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 381
TABLE 383 SOUTH KOREA: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 382
TABLE 384 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 382
TABLE 385 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 383
TABLE 386 REST OF ASIA PACIFIC: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 383
TABLE 387 REST OF ASIA PACIFIC: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 384
TABLE 388 REST OF ASIA PACIFIC: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 384
TABLE 389 REST OF ASIA PACIFIC: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 385
TABLE 390 REST OF ASIA PACIFIC: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 385
TABLE 391 REST OF ASIA PACIFIC: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 385
TABLE 392 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 386
TABLE 393 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 386
TABLE 394 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 387
TABLE 395 LATIN AMERICA: INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 388
TABLE 396 LATIN AMERICA: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 388
TABLE 397 LATIN AMERICA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 389
TABLE 398 LATIN AMERICA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 389
TABLE 399 LATIN AMERICA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 390
TABLE 400 LATIN AMERICA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 390
TABLE 401 LATIN AMERICA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 391
TABLE 402 LATIN AMERICA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 391
TABLE 403 LATIN AMERICA: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 391
TABLE 404 LATIN AMERICA: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 392
TABLE 405 LATIN AMERICA: INFUSION PUMPS MARKET, BY END USER
2023–2030 (USD MILLION) 392
TABLE 406 LATIN AMERICA: INFUSION PUMPS MARKET, BY APPLICATION
2023–2030 (USD MILLION) 393
TABLE 407 BRAZIL: MACROECONOMIC INDICATORS 394
TABLE 408 BRAZIL: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 394
TABLE 409 BRAZIL: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 394
TABLE 410 BRAZIL: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2023–2030 (USD MILLION) 395
TABLE 411 BRAZIL: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 396
TABLE 412 BRAZIL: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 396
TABLE 413 BRAZIL: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 397
TABLE 414 BRAZIL: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 397
TABLE 415 BRAZIL: INFUSION PUMP DEVICES MARKET, BY MODE, 2023–2030 (USD MILLION) 397
TABLE 416 BRAZIL: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 398
TABLE 417 BRAZIL: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 398
TABLE 418 BRAZIL: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 399
TABLE 419 MEXICO: MACROECONOMIC INDICATORS 400
TABLE 420 MEXICO: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 400
TABLE 421 MEXICO: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES,
BY TYPE, 2023–2030 (USD MILLION) 400
TABLE 422 MEXICO: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 401
TABLE 423 MEXICO: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 402
TABLE 424 MEXICO: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 402
TABLE 425 MEXICO: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 403
TABLE 426 MEXICO: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 403
TABLE 427 MEXICO: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 403
TABLE 428 MEXICO: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2023–2030 (USD MILLION) 404
TABLE 429 MEXICO: INFUSION PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 404
TABLE 430 MEXICO: INFUSION PUMPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 405
TABLE 431 REST OF LATIN AMERICA: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 406
TABLE 432 REST OF LATIN AMERICA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 406
TABLE 433 REST OF LATIN AMERICA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 407
TABLE 434 REST OF LATIN AMERICA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 408
TABLE 435 REST OF LATIN AMERICA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 408
TABLE 436 REST OF LATIN AMERICA: AMBULATORY INFUSION PUMPS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 409
TABLE 437 REST OF LATIN AMERICA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 409
TABLE 438 REST OF LATIN AMERICA: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 409
TABLE 439 REST OF LATIN AMERICA: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 410
TABLE 440 REST OF LATIN AMERICA: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 410
TABLE 441 REST OF LATIN AMERICA: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 411
TABLE 442 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 412
TABLE 443 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 412
TABLE 444 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 413
TABLE 445 MIDDLE EAST & AFRICA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 413
TABLE 446 MIDDLE EAST & AFRICA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 414
TABLE 447 MIDDLE EAST & AFRICA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 414
TABLE 448 MIDDLE EAST & AFRICA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 415
TABLE 449 MIDDLE EAST & AFRICA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 415
TABLE 450 MIDDLE EAST & AFRICA: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 415
TABLE 451 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 416
TABLE 452 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 416
TABLE 453 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 417
TABLE 454 GCC COUNTRIES: INFUSION PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 418
TABLE 455 GCC COUNTRIES: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 418
TABLE 456 GCC COUNTRIES: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 418
TABLE 457 GCC COUNTRIES: DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2023–2030 (USD MILLION) 419
TABLE 458 GCC COUNTRIES: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 420
TABLE 459 GCC COUNTRIES: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 420
TABLE 460 GCC COUNTRIES: AMBULATORY INFUSION PUMPS MARKET, BY TYPE,
2023–2030 (USD MILLION) 421
TABLE 461 GCC COUNTRIES: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 421
TABLE 462 GCC COUNTRIES: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 421
TABLE 463 GCC COUNTRIES: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 422
TABLE 464 GCC COUNTRIES: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 422
TABLE 465 GCC COUNTRIES: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 423
TABLE 466 KINGDOM OF SAUDI ARAB: KEY MACROINDICATORS 424
TABLE 467 KINGDOM OF SAUDI ARABIA: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 424
TABLE 468 KINGDOM OF SAUDI ARABIA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 425
TABLE 469 KINGDOM OF SAUDI ARABIA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 425
TABLE 470 KINGDOM OF SAUDI ARABIA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 426
TABLE 471 KINGDOM OF SAUDI ARABIA: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 426
TABLE 472 KINGDOM OF SAUDI ARABIA: AMBULATORY INFUSION PUMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 427
TABLE 473 KINGDOM OF SAUDI ARABIA: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 427
TABLE 474 KINGDOM OF SAUDI ARABIA: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 427
TABLE 475 KINGDOM OF SAUDI ARABIA: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 428
TABLE 476 KINGDOM OF SAUDI ARABIA: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 428
TABLE 477 KINGDOM OF SAUDI ARABIA: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 429
TABLE 478 UNITED ARAB EMIRATES: KEY MACROINDICATORS 430
TABLE 479 UNITED ARAB EMIRATES: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 430
TABLE 480 UNITED ARAB EMIRATES: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 430
TABLE 481 UNITED ARAB EMIRATES: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 431
TABLE 482 UNITED ARAB EMIRATES (UAE): NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 432
TABLE 483 UNITED ARAB EMIRATES: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 432
TABLE 484 UNITED ARAB EMIRATES: AMBULATORY INFUSION PUMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 433
TABLE 485 UNITED ARAB EMIRATES: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 433
TABLE 486 UNITED ARAB EMIRATES: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 433
TABLE 487 UNITED ARAB EMIRATES: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 434
TABLE 488 UNITED ARAB EMIRATES: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 434
TABLE 489 UNITED ARAB EMIRATES: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 435
TABLE 490 OTHER GCC COUNTRIES: INFUSION PUMPS MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 436
TABLE 491 OTHER GCC COUNTRIES: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 436
TABLE 492 OTHER GCC COUNTRIES: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 437
TABLE 493 OTHER GCC COUNTRIES: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 438
TABLE 494 OTHER GCC COUNTRIES: INFUSION PUMP DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 438
TABLE 495 OTHER GCC COUNTRIES: AMBULATORY INFUSION PUMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 439
TABLE 496 OTHER GCC COUNTRIES: INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 439
TABLE 497 OTHER GCC COUNTRIES: INFUSION PUMP DEVICES MARKET, BY MODE,
2023–2030 (USD MILLION) 439
TABLE 498 OTHER GCC COUNTRIES: INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 440
TABLE 499 OTHER GCC COUNTRIES: INFUSION PUMPS MARKET, BY END USER,
2023–2030 (USD MILLION) 440
TABLE 500 OTHER GCC COUNTRIES: INFUSION PUMPS MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 441
TABLE 501 REST OF MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 442
TABLE 502 REST OF MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2023–2030 (USD MILLION) 442
TABLE 503 REST OF MIDDLE EAST & AFRICA: DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 443
TABLE 504 REST OF MIDDLE EAST & AFRICA: NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 444
TABLE 505 REST OF MIDDLE EAST & AFRICA: INFUSION PUMP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 444
TABLE 506 REST OF MIDDLE EAST & AFRICA: AMBULATORY INFUSION PUMPS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 445
TABLE 507 REST OF MIDDLE EAST & AFRICA: INFUSION PUMP DEVICES MARKET,
BY TECHNOLOGY, 2023–2030 (USD MILLION) 445
TABLE 508 REST OF MIDDLE EAST & AFRICA: INFUSION PUMP DEVICES MARKET, BY MODE, 2023–2030 (USD MILLION) 445
TABLE 509 REST OF MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET,
BY MODE OF ADMINISTRATION, 2023–2030 (USD MILLION) 446
TABLE 510 REST OF MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET,
BY END USER, 2023–2030 (USD MILLION) 446
TABLE 511 REST OF MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET,
BY APPLICATION, 2023–2030 (USD MILLION) 447
TABLE 512 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN
INFUSION PUMPS MARKET 449
TABLE 513 INFUSION PUMPS MARKET: DEGREE OF COMPETITION 457
TABLE 514 INFUSION PUMPS MARKET: REGION FOOTPRINT 462
TABLE 515 INFUSION PUMPS MARKET: PRODUCT FOOTPRINT 463
TABLE 516 INFUSION PUMPS MARKET: MODE OF ADMINISTRATION FOOTPRINT 464
TABLE 517 INFUSION PUMPS MARKET: APPLICATION FOOTPRINT 465
TABLE 518 INFUSION PUMPS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 468
TABLE 519 INFUSION PUMPS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 469
TABLE 520 INFUSION PUMPS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022−JUNE 2025 472
TABLE 521 INFUSION PUMPS MARKET: DEALS, JANUARY 2022−JUNE 2025 474
TABLE 522 INFUSION PUMPS MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 475
TABLE 523 INFUSION PUMPS MARKET: OTHER DEVELOPMENTS, JANUARY 2022−MAY 2025 476
TABLE 524 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 477
TABLE 525 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 478
TABLE 526 BECTON, DICKINSON AND COMPANY: PRODUCT APPROVALS,
JANUARY 2022−JUNE 2025 483
TABLE 527 BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2022−JUNE 2025 484
TABLE 528 BECTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2022–JUNE 2025 484
TABLE 529 BD: OTHER DEVELOPMENTS, JANUARY 2022−JUNE 2025 485
TABLE 530 BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW 487
TABLE 531 BAXTER INTERNATIONAL, INC.: PRODUCTS OFFERED 488
TABLE 532 BAXTER INTERNATIONAL, INC.: PRODUCT LAUNCHES, JANUARY 2022−JUNE 2025 490
TABLE 533 BAXTER INTERNATIONAL, INC.: DEALS, JANUARY 2022−JUNE 2025 490
TABLE 534 BAXTER INTERNATIONAL, INC.: OTHER DEVELOPMENTS,
JANUARY 2022−JUNE 2025 491
TABLE 535 B. BRAUN SE: COMPANY OVERVIEW 493
TABLE 536 B. BRAUN SE: PRODUCTS OFFERED 494
TABLE 537 B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2025 497
TABLE 538 B. BRAUN SE: DEALS, JANUARY 2022–JUNE 2025 498
TABLE 539 INFUSION PUMPS MARKET: OTHER DEVELOPMENTS, JANUARY 2022−JUNE 2025 498
TABLE 540 MEDTRONIC: COMPANY OVERVIEW 500
TABLE 541 MEDTRONIC: PRODUCTS OFFERED 501
TABLE 542 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–JUNE 2025 502
TABLE 543 MEDTRONIC: DEALS, JANUARY 2022–JUNE 2025 503
TABLE 544 FRESENIUS KABI AG: COMPANY OVERVIEW 506
TABLE 545 FRESENIUS KABI AG: PRODUCTS OFFERED 508
TABLE 546 FRESENIUS KABI AG: PRODUCT APPROVALS, JANUARY 2022–JUNE 2025 511
TABLE 547 FRESENIUS KABI AG: DEALS, JANUARY 2022–JUNE 2025 511
TABLE 548 FRESENIUS KABI AG: OTHER DEVELOPMENTS, JANUARY 2022−JUNE 2025 512
TABLE 549 ICU MEDICAL, INC.: BUSINESS OVERVIEW 514
TABLE 550 ICU MEDICAL, INC.: PRODUCTS OFFERED 515
TABLE 551 ICU MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2025 517
TABLE 552 ICU MEDICAL, INC.: DEALS, JANUARY 2022–JUNE 2025 517
TABLE 553 ICU MEDICAL, INC.: OTHER DEVELOPMENTS, JANUARY 2022-JUNE 2025 517
TABLE 554 TERUMO CORPORATION: COMPANY OVERVIEW 518
TABLE 555 TERUMO CORPORATION: PRODUCTS OFFERED 519
TABLE 556 TERUMO CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 520
TABLE 557 TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2025 521
TABLE 558 TERUMO CORPORATION: DEALS, JANUARY 2022–JUNE 2025 521
TABLE 559 NIPRO: COMPANY OVERVIEW 522
TABLE 560 NIPRO: PRODUCTS OFFERED 523
TABLE 561 NIPRO: EXPANSIONS, JANUARY 2022–JUNE 2025 525
TABLE 562 AVANOS MEDICAL, INC.: COMPANY OVERVIEW 526
TABLE 563 AVANOS MEDICAL, INC.: PRODUCTS OFFERED 528
TABLE 564 INSULET CORPORATION: COMPANY OVERVIEW 529
TABLE 565 INSULET CORPORATION: PRODUCTS OFFERED 530
TABLE 566 INSULET CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2025 531
TABLE 567 INSULET CORPORATION: DEALS, JANUARY 2022−JUNE 2025 532
TABLE 568 INSULET CORPORATION: EXPANSIONS, JANUARY 2022−JUNE 2025 532
TABLE 569 TANDEM DIABETES CARE, INC.: COMPANY OVERVIEW 533
TABLE 570 TANDEM DIABETES CARE, INC.: PRODUCTS OFFERED 534
TABLE 571 TANDEM DIABETES CARE, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022−JUNE 2025 535
TABLE 572 TANDEM DIABETES CARE, INC.: DEALS, JANUARY 2022−JUNE 2025 536
TABLE 573 JMS CO., LTD.: COMPANY OVERVIEW 537
TABLE 574 JMS CO., LTD.: PRODUCTS OFFERED 539
TABLE 575 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 540
TABLE 576 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 542
TABLE 577 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS,
JANUARY 2022−JUNE 2025 542
TABLE 578 MOOG, INC.: COMPANY OVERVIEW 543
TABLE 579 MOOG, INC.: PRODUCTS OFFERED 544
TABLE 580 MOOG, INC.: PRODUCT LAUNCHES & ENHANCEMENTS,
JANUARY 2022−JUNE 2025 546
TABLE 581 MOOG INC.: OTHER DEVELOPMENTS, JANUARY 2022−JUNE 2025 546
TABLE 582 TELEFLEX INCORPORATED: COMPANY OVERVIEW 547
TABLE 583 TELEFLEX INCORPORATED: PRODUCTS OFFERED 548
TABLE 584 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 549
TABLE 585 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 551
TABLE 586 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 551
TABLE 587 YPSOMED: COMPANY OVERVIEW 552
TABLE 588 YPSOMED: PRODUCTS OFFERED 553
TABLE 589 YPSOMED: PRODUCT LAUNCHES & ENHANCEMENTS, JANUARY 2022–JUNE 2025 554
TABLE 590 YPSOMED: DEALS, JANUARY 2022–JUNE 2025 555
TABLE 591 YPSOMED: EXPANSIONS, JANUARY 2022–JUNE 2025 556
TABLE 592 POLYMEDICURE: COMPANY OVERVIEW 557
TABLE 593 POLYMEDICURE: PRODUCTS OFFERED 558
TABLE 594 ROMSONS.IN: COMPANY OVERVIEW 560
TABLE 595 ROMSONS.IN: PRODUCTS OFFERED 561
TABLE 596 PROMED TECHNOLOGY CO., LIMITED: COMPANY OVERVIEW 562
TABLE 597 PROMED TECHNOLOGY CO., LIMITED: PRODUCTS OFFERED 562
TABLE 598 MEDCAPTAIN MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 564
TABLE 599 MEDCAPTAIN MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED 564
TABLE 600 MICREL MEDICAL DEVICES SA: COMPANY OVERVIEW 566
TABLE 601 INTUVIE HOLDINGS LLC: COMPANY OVERVIEW 567
TABLE 602 EPIC MEDICAL: COMPANY OVERVIEW 568
TABLE 603 SOOIL DEVELOPMENTS CO., LTD.: COMPANY OVERVIEW 569
TABLE 604 SHENZHEN MEDRENA BIOTECH CO., LTD: COMPANY OVERVIEW 570
TABLE 605 CODAN COMPANIES: COMPANY OVERVIEW 571
TABLE 606 EITAN MEDICAL: COMPANY OVERVIEW 572
TABLE 607 ANGIPLAST PRIVATE LIMITED: COMPANY OVERVIEW 573
TABLE 608 BEIJING KELLYMED CO.: COMPANY OVERVIEW 574
LIST OF FIGURES
FIGURE 1 INFUSION PUMPS MARKET SEGMENTATION 44
FIGURE 2 INFUSION PUMPS MARKET: RESEARCH DESIGN 49
FIGURE 3 PRIMARY SOURCES 52
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION (SUPPLY SIDE) 54
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION (DEMAND SIDE) 54
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 55
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 56
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY 56
FIGURE 9 REVENUE ANALYSIS OF TOP FIVE COMPANIES: INFUSION PUMPS MARKET (2024) 57
FIGURE 10 INFUSION PUMPS MARKET: DEMAND-SIDE ANALYSIS 58
FIGURE 11 BD (ALARIS): REVENUE APPROACH 59
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF INFUSION PUMPS MARKET (2025–2030) 60
FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 60
FIGURE 14 TOP-DOWN APPROACH 61
FIGURE 15 BOTTOM-UP APPROACH 62
FIGURE 16 MARKET DATA TRIANGULATION METHODOLOGY 63
FIGURE 17 INFUSION PUMPS MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 67
FIGURE 18 INFUSION PUMPS MARKET FOR ACCESSORIES AND CONSUMABLES, BY TYPE, 2025 VS. 2030 (USD MILLION) 68
FIGURE 19 DEDICATED ACCESSORIES AND CONSUMABLES MARKET, BY TYPE,
2025 VS. 2030 (USD MILLION) 69
FIGURE 20 NON-DEDICATED ACCESSORIES AND CONSUMABLES MARKET,
BY TYPE, 2025 VS. 2030 (USD MILLION) 70
FIGURE 21 INFUSION PUMP DEVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 71
FIGURE 22 INFUSION PUMP DEVICES MARKET, BY TECHNOLOGY,
2025 VS. 2030 (USD MILLION) 72
FIGURE 23 INFUSION PUMP DEVICES MARKET, BY MODE, 2025 VS. 2030 (USD MILLION) 72
FIGURE 24 INFUSION PUMPS MARKET, BY MODE OF ADMINISTRATION,
2025 VS. 2030 (USD MILLION) 73
FIGURE 25 INFUSION PUMPS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 74
FIGURE 26 INFUSION PUMPS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 75
FIGURE 27 GEOGRAPHIC GROWTH OPPORTUNITIES 76
FIGURE 28 RISING TECHNOLOGICAL ADVANCEMENTS FOR DEVELOPMENT OF SMART INFUSION PUMPS TO PROPEL MARKET 78
FIGURE 29 CHEMOTHERAPY/ONCOLOGY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN APAC IN 2024 79
FIGURE 30 ASIA PACIFIC REGION TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 80
FIGURE 31 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 81
FIGURE 32 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 82
FIGURE 33 INFUSION PUMPS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 84
FIGURE 34 INFUSION PUMPS MARKET: PORTER’S FIVE FORCES ANALYSIS 105
FIGURE 35 INFUSION PUMPS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2014–MAY 2025) 113
FIGURE 36 TOP APPLICANT COUNTRIES/REGIONS FOR INFUSION PUMP PATENTS (JANUARY 2014–MAY 2025) 114
FIGURE 37 AVERAGE SELLING PRICE TREND FOR VOLUMETRIC & SYRINGE INFUSION PUMPS, BY KEY PLAYER, 2024 118
FIGURE 38 AVERAGE SELLING PRICE FOR INFUSION CATHETERS & NEEDLESS
CONNECTORS, BY KEY PLAYER, 2024 119
FIGURE 39 AVERAGE SELLING PRICE FOR VOLUMETRIC INFUSION PUMPS, INSULIN PUMPS, AND SYRINGE INFUSION PUMPS, BY REGION, 2024 120
FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INFUSION PUMPS 126
FIGURE 41 KEY BUYING CRITERIA FOR INFUSION PUMPS FOR TOP 3 END USERS 127
FIGURE 42 AI USE CASES 129
FIGURE 43 INFUSION PUMPS MARKET: ECOSYSTEM MAP 131
FIGURE 44 INFUSION PUMPS MARKET: VALUE CHAIN ANALYSIS 135
FIGURE 45 INFUSION PUMPS MARKET: SUPPLY CHAIN ANALYSIS 136
FIGURE 46 INFUSION PUMPS MARKET: ADJACENT MARKETS 136
FIGURE 47 REVENUE SHIFTS & NEW REVENUE POCKETS FOR INFUSION PUMPS MARKET 137
FIGURE 48 GEOGRAPHIC SNAPSHOT OF INFUSION PUMPS MARKET 265
FIGURE 49 NORTH AMERICA: INFUSION PUMPS MARKET SNAPSHOT 267
FIGURE 50 EUROPE: NUMBER OF CRITICAL BEDS PER 100,000 POPULATION,
BY COUNTRY, 2023 285
FIGURE 51 ASIA PACIFIC: INFUSION PUMPS MARKET SNAPSHOT 335
FIGURE 52 REVENUE ANALYSIS OF KEY PLAYERS IN INFUSION PUMPS MARKET (2020−2024) 451
FIGURE 53 MARKET SHARE ANALYSIS OF KEY PLAYERS IN INFUSION PUMPS MARKET (2024) 452
FIGURE 54 VOLUMETRIC INFUSION PUMPS MARKET SHARE, BY KEY PLAYER, 2024 453
FIGURE 55 SYRINGE INFUSION PUMPS MARKET SHARE, BY KEY PLAYER, 2024 453
FIGURE 56 INSULIN PUMPS MARKET SHARE, BY KEY PLAYER, 2024 454
FIGURE 57 ENTERAL INFUSION PUMPS MARKET SHARE, BY KEY PLAYER, 2024 454
FIGURE 58 US: INFUSION PUMPS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2024 455
FIGURE 59 EUROPE: INFUSION PUMPS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2024 456
FIGURE 60 US: INSULIN PUMPS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2024 456
FIGURE 61 RANKING OF KEY PLAYERS IN INFUSION PUMPS MARKET, 2024 457
FIGURE 62 INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 460
FIGURE 63 INFUSION PUMPS MARKET: COMPANY FOOTPRINT 461
FIGURE 64 INFUSION PUMPS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 467
FIGURE 65 INFUSION PUMPS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 470
FIGURE 66 R&D EXPENDITURE OF KEY PLAYERS IN INFUSION PUMPS MARKET, 2022−2024 471
FIGURE 67 EV/EBITDA OF KEY VENDORS 471
FIGURE 68 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 472
FIGURE 69 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024) 478
FIGURE 70 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2024) 488
FIGURE 71 B. BRAUN SE: COMPANY SNAPSHOT (2023) 494
FIGURE 72 MEDTRONIC: COMPANY SNAPSHOT (2024) 501
FIGURE 73 FRESENIUS KABI AG: COMPANY SNAPSHOT (2024) 507
FIGURE 74 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 515
FIGURE 75 TERUMO CORPORATION: COMPANY SNAPSHOT (2023) 519
FIGURE 76 NIPRO: COMPANY SNAPSHOT (2024) 523
FIGURE 77 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2024) 527
FIGURE 78 INSULET CORPORATION: COMPANY SNAPSHOT (2024) 530
FIGURE 79 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2024) 534
FIGURE 80 JMS CO., LTD.: COMPANY SNAPSHOT (2023) 538
FIGURE 81 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024) 541
FIGURE 82 MOOG, INC.: COMPANY SNAPSHOT (2024) 544
FIGURE 83 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024) 548
FIGURE 84 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY SNAPSHOT (2023) 550
FIGURE 85 YPSOMED: COMPANY SNAPSHOT (2024) 553
FIGURE 86 POLYMEDICURE: COMPANY SNAPSHOT (2023) 558
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11